Literature DB >> 3085094

Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

F Malavasi, C Tetta, A Funaro, G Bellone, E Ferrero, A C Franzone, P Dellabona, R Rusci, L Matera, G Camussi.   

Abstract

Triggering of large granular lymphocyte (LGL) Fc receptor with a specific monoclonal antibody (AB8.28) linked to an insoluble matrix induces cell activation, as witnessed by expression of HLA class II (DR and DQ) molecules and interleukin 2 receptor. Moreover, this event is accompanied by a concomitant release of platelet-activating factor by LGL. We conclude that the Fc receptor molecule identified by mAb AB8.28 represents a trigger for LGL activation.

Mesh：

Substances：

Year:  1986        PMID： 3085094      PMCID： PMC323314          DOI： 10.1073/pnas.83.8.2443

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  25 in total

1.  Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity.

Authors:  F Malavasi; A Funaro; G Bellone; F Caligaris-Cappio; E Berti; C Tetta; P Dellabona; S DeMaria; M Campogrande; A P Cappa
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

2.  Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.

Authors:  P M Henson
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

Authors:  G Camussi; M Aglietta; R Coda; F Bussolino; W Piacibello; C Tetta
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

4.  HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays.

Authors:  A Ziegler; B Uchańska-Ziegler; J Zeuthen; P Wernet
Journal:  Somatic Cell Genet       Date:  1982-11

5.  Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.

Authors:  M L Blank; F Snyder
Journal:  J Chromatogr       Date:  1983-04-08

6.  Cultures of purified human natural killer cells: growth in the presence of interleukin 2.

Authors:  T Timonen; J R Ortaldo; B M Stadler; G D Bonnard; S O Sharrow; R B Herberman
Journal:  Cell Immunol       Date:  1982-09-01       Impact factor: 4.868

7.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

Authors:  R N Pinckard; R S Farr; D J Hanahan
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

8.  Characterization of an antigen expressed by human natural killer cells.

Authors:  J D Griffin; T Hercend; R Beveridge; S F Schlossman
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Biosynthesis and release of platelet-activating factor from human monocytes.

Authors:  G Camussi; F Bussolino; C Tetta; W Piacibello; M Aglietta
Journal:  Int Arch Allergy Appl Immunol       Date:  1983-03

10.  Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.

Authors:  D W Goldman; E J Goetzl
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422
View more
  15 in total

1.  Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.

Authors:  I Kudo; T Kato; H Hayashi; R Yanoshita; K Ikizawa; H Uda; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.

Authors:  N M Ruis; J K Rose; F H Valone
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

Authors:  L B DeMonte; P Nistico; R Tecce; P Dellabona; M Momo; A Anichini; M Mariani; P G Natali; F Malavasi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium.

Authors:  R Gavioli; S Spisani; A L Giuliani; S Traniello
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

5.  Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Authors:  M Watanabe; M Yamada; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.

Authors:  Y Mandi; G Farkas; M Koltai; I Beladi; J M Mencia-Huerta; P Braquet
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

7.  Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.

Authors:  P Nisticò; R Mortarini; L B De Monte; A Mazzocchi; M Mariani; F Malavasi; G Parmiani; P G Natali; A Anichini
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 8.  Functional regulation of human neutrophil Fc gamma receptors.

Authors:  Periasamy Selvaraj; Nimita Fifadara; Shanmugam Nagarajan; Ashley Cimino; Guixian Wang
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells.

Authors:  M R Capobianchi; F Malavasi; P Di Marco; F Dianzani
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 10.  The potential pathophysiological role of platelet-activating factor in human diseases.

Authors:  C Kroegel
Journal:  Klin Wochenschr       Date:  1988-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.